Phase I/II Study, Administration of AdVEGF-All6A+, a Replication Deficient Adenovirus Vector Expressing a cDNA/Genomic Hybrid of Human Vascular Endothelial Growth Factor to the Ischemic Myocardium of Individuals With Diffuse Coronary Artery Disease Via Minimally Invasive Surgery
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Vascular endothelial growth factor gene therapy (Primary)
- Indications Coronary artery disease
- Focus Therapeutic Use
- 27 Jan 2021 Biomarkers information updated
- 22 Jan 2013 New trial record